Posted Friday, July 22, 2022
CMS has released the July, 2022 Quarterly Outcome and Assessment Information Set (OASIS) FAQs.
The release clarifies questions on items that are included in the OASIS-E. Items D0150 and D0160, Patient Mood Interview (PHQ2-9), are addressed regarding scoring for the total points and when the interview should be stopped after completing D0150A and D0150B.
CMS notes that at times it provides new or refined instruction in the FAQs document that supersedes previously published guidance. In such cases, use the most recent guidance. Note that this guidance supersedes instruction provided in the draft OASIS-E Guidance Manual, posted May 2022.
CMS answered one question on item N0415 – High Risk Drug Classes, which clarifies how specific the documented indication must be.
Several questions on items GG0130 and GG0170 around self-care and mobility and walking and wheelchair activities are included. Along with one question on items M2020and M2030 that asks CMS to explain what is meant by “routinely stored” for medication management.
Source: NAHC Report
Corridor’s experts are ready to support your clinicians’ transition to OASIS-E. Whether through OASIS review, clinical documentation improvement, clinician education, or all of the above, we’ve got you covered. Contact Us today to learn more!
About Corridor
For over 30 years, Corridor has partnered with home-based care providers, delivering powerful solutions to support the unique challenges of caring for patients in the home. Our team of operating executives, clinicians, and nationally renowned industry experts have run provider organizations and resolved the same challenges you face.
To receive the most important industry updates, insights and news impacting home health and hospice, please make sure to sign up for our weekly newsletter
